Critical evaluation of a decision-analytic model of major depression treatment

Research output: Contribution to journalArticle


Antidepressants are typically one of the most costly drug classes in the drug budget. Due to the higher costs of many of the newer antidepressants, a number of studies have been conducted to evaluate the clinical and cost aspects of depression treatment. The purpose of this month's Practical Pharmacoeconomics column is to assist readers in interpreting a cost- effectiveness evaluation of antidepressant drugs that used a decision tree model to assess the treatment of major depression.

Original languageEnglish (US)
Pages (from-to)683-687
Number of pages5
Issue number8
Publication statusPublished - Aug 1999


ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this